0001683168-22-002002.txt : 20220328 0001683168-22-002002.hdr.sgml : 20220328 20220328171450 ACCESSION NUMBER: 0001683168-22-002002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220324 FILED AS OF DATE: 20220328 DATE AS OF CHANGE: 20220328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PARSLOW JAMES F CENTRAL INDEX KEY: 0001285943 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37937 FILM NUMBER: 22776356 MAIL ADDRESS: STREET 1: C/O XENETIC BIOSCIENCES, INC. STREET 2: 99 HAYDEN AVENUE, SUITE 230 CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xenetic Biosciences, Inc. CENTRAL INDEX KEY: 0001534525 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452952962 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 SPEEN STREET, SUITE 102 CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 781-778-7720 MAIL ADDRESS: STREET 1: 40 SPEEN STREET, SUITE 102 CITY: FRAMINGHAM STATE: MA ZIP: 01701 FORMER COMPANY: FORMER CONFORMED NAME: General Sales & Leasing, Inc. DATE OF NAME CHANGE: 20130227 FORMER COMPANY: FORMER CONFORMED NAME: GENERAL AIRCRAFT INC. DATE OF NAME CHANGE: 20111108 4 1 ownership.xml X0306 4 2022-03-24 0 0001534525 Xenetic Biosciences, Inc. XBIO 0001285943 PARSLOW JAMES F 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 0 1 0 0 Chief Financial Officer Stock Options 1.12 2022-03-24 4 A 0 50000 0 A 2032-03-24 Common Stock 50000 50000 D The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 24, 2022; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 24, 2023 and ending on March 24, 2025. /s/ James Parslow 2022-03-28